Video discussion about the problems with short term health plans – also known as "skinny plans," which may have lower monthly premiums, but will not provide the benefits or protections required by the ACA.
Importation of prescription drugs to lower costs is being proposed by the Trump Administration using demonstration projects and other pathways. Safety concerns and monitoring have yet to be addressed, but it could be human experimentation without informed
Insurance companies sometimes try to cut costs by substituting less expensive drugs for a specific drug prescription. That's raising problems in many cases, and actually causing harm.
Health reform proposals like Medicare-for-all or Single Payer would shift around the health care system and could produce cost savings, but those savings would in part come from the elimination of jobs for insurance brokers, hospital staff, and others.
Congressional Budget Office experts outlined the complexities of implementing an overhaul of America’s health insurance system.
Opioids such as heroin and fentanyl, continue to harm women and families. Women are at greater risk for OUD because of biologic differences, and women also have higher rates of chronic pain.
African-American women aging with HIV often have histories of abuse and trauma, in addition to other medical conditions. A few share their stories.
Experienced health care journalists discuss Medicare for all (also known as Single Payer) and why enthusiasm may be decreasing; proposals to increase the age to purchase tobacco; and surprise medical bills.
Protections for preexisting conditions for most people with job-based insurance predated the Affordable Care Act by more than a decade.
Women who are subject to violence – often from intimate partners – are more likely to turn to opioids or other substances leading to further health and life problems, including increased risk for HIV infection.
Treatment of Opioid Use Disorder in California with Medication Assisted Treatment (MAT) has increased through greater use of Buprenorphine – one of two major medicines used to treat OUD.
Limiting surprise medical bills – when someone gets a bill for health care that is much larger than they had expected is an area of bipartisan agreement in Congress.
Rebates paid from pharmaceutical companies to pharmaceutical benefit managers are increasing, driving up costs for patients, and possibly increasing overall drug spending and prices.